Skip to main content

Gyrodyne, LLC

corporate_fare Company Profile

Gyrodyne, LLC

GYRO·NASDAQ·Real Estate & Construction·CIK 0001589061

Gyrodyne, LLC is a New York-based limited liability company primarily engaged in managing a portfolio of medical office and industrial properties. The company also focuses on obtaining entitlements for these properties, which are located in Suffolk ("Flowerfield") and Westchester ("Cortlandt Manor") Counties, New York. The majority of Gyrodyne's developed properties are leased under agreements where tenants reimburse the company for a portion, all, or substantially all of the costs and/or cost increases related to utilities, insurance, repairs, maintenance, and real estate taxes. However, some leases stipulate that Gyrodyne is responsible for certain operating expenses. Gyrodyne's corporate strategy aims to increase the value of its Flowerfield and Cortlandt Manor properties. This is achieved by pursuing entitlement opportunities to offer purchasers greater development flexibility and by enhancing the value of its existing leases. The real estate value reported in the consolidated statement of net assets as of December 31, 2025, and December 31, 2024, reflects some, but not all, of the potential value impact from these enhancement efforts. Gyrodyne intends to dissolve after selling all its real property assets, using the proceeds to settle any debts and claims, and then distributing the remainder to common shareholders.

Gyrodyne, LLC (NASDAQ:GYRO) is a publicly traded company in the Real Estate & Construction sector. Wiseek has independently scored 4 items for GYRO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-13, rated 7/10. Across its 4 most recent items scored 7 or higher, the top rating is 9/10, with 2 rated 8 or above. Recent SEC coverage for GYRO spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • Gyrodyne 10-Q: COO Exit Saves $620K, Leaves One Employee to Finish Liquidation
  • Gyrodyne COO Peter Pitsiokos to Depart; Company Down to One Full-Time Employee
  • Gyrodyne, LLC Reports Significant Decline in Net Assets and Extends Liquidation Timeline to 2028 Amid Financial Strain and High-Interest Debt
  • Gyrodyne Amends Property Sale Agreement, Grants $1.52M Credit to Buyer, Adds New Termination Risk

Financial Snapshot

Fiscal year ended December 31, 2025
Cash & Equivalents
$4.53M
Shares Outstanding
2.2M sh
Source: 10-K · filed 2026-03-27 · accession 0001437749-26-010078

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 445 shares in GYRO as of the September 15, 2026 settlement, a 6.7% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On October 2, 2026, 66.9% of GYRO volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)445 shares as of September 15, 2026
Change vs prior period▲ 6.7%
Days to cover1.00 at avg daily volume of 3,489
Daily short volume (FINRA facilities)66.9% of 3,396 shares on October 2, 2026
4-day average short volume75.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with G →
$4.56 -0.13% today
52-week range · as of 2026-08-13 $4.56 – $12
Market cap
$10.03M
Volume
12.6K (3.4× avg)
3-mo avg 3.7K
Live data · 2026-10-05 04:25 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed GYRO - Latest Insights

GYRO
Aug 13, 2026, 6:06 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $5.36
Real-time Price: $4.56 info
Change: -$0.8001 (-15%) info
Market Cap: $10.029M info
GYRO
Aug 07, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.40
Real-time Price: $4.56 info
Change: -$0.8401 (-16%) info
Market Cap: $10.029M info
GYRO
Mar 27, 2026, 4:00 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $7.99
Real-time Price: $4.56 info
Change: -$3.43 (-43%) info
Market Cap: $10.029M info
GYRO
Jan 12, 2026, 5:26 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.06
Real-time Price: $4.56 info
Change: -$4.50 (-50%) info
Market Cap: $10.029M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets